NHSA Report: China’s Medical Insurance Fund Records Significant Growth and Savings in 2023
The National Healthcare Security Administration (NHSA) has released its comprehensive annual statistical report for the...
Policy / Regulatory
China’s NMPA Suspends Daewoong Bio’s Antibiotic, Excludes Firm from National Procurement Program
The National Medical Products Administration (NMPA) in China has taken a decisive step to suspend...
China’s NHSA Updates DRG/DIP Payment Reform Program with New Exclusion Mechanisms and Timelines
The National Healthcare Security Administration (NHSA) in China has issued a notification outlining several updates...
WuXi AppTec Spends Over USD 360,000 on US Lobbying Amid Biosecure Act Deliberations
Endpoints News has reported that WuXi AppTec Co., Ltd, (SHA: 603259) a China-based Contract Development...
NMPA Suspends Import and Sale of SAMO S.p.A Knee and Hip Prosthesis Systems
The National Medical Products Administration (NMPA) has issued a notice to suspend the import, sale,...
China’s NMPA and NHC Implement New Rules for Temporary Import of Urgent Medical Devices
The National Medical Products Administration (NMPA) and the National Health Commission have issued the Management...
China Unveils Ambitious Healthcare Reforms at 20th Central Committee Plenary Session
The third plenary session of the 20th Central Committee of the Communist Party of China...
China Issues Ethical Guidelines for Human Genome Editing, Prohibits Germline Editing
China’s Ministry of Science and Technology (MOST) has issued the Ethical Guidelines for Human Genome...
NHSA Mandates Standardized Online Procurement for Injectable Drugs to Ensure Pricing Transparency
The National Healthcare Security Administration (NHSA) has issued a directive to standardize the procurement process...
Novo Nordisk Faces US Senators’ Scrutiny Over Levemir Withdrawal
US senators, including Jeanne Shaheen, Raphael Warnock, and Elizabeth Warren, have voiced concerns over Novo...
U.S. Senate Passes Affordable Prescriptions for Patients Act to Limit Patent Thicketing
In a significant move to curb drug prices, the U.S. Senate unanimously passed the Affordable...
US House Speaker Mike Johnson Revives Possibility of Biosecure Act Vote
US House of Representatives Speaker Mike Johnson has suggested that a vote on the Biosecure...
China’s State Council Reportedly Approves Plan to Support Full Industry Chain of Innovative Drug Development
A State Council executive meeting, chaired by Chinese Premier Li Qiang, reportedly approved an “Implementation...
LEK Consulting’s Survey Reveals Biosecure Act’s Impact on Life Sciences Companies
LEK Consulting, a UK/US firm, has published the results of a global survey aimed at...
US Forms ‘Bio-5’ Coalition with Global Powers to Reduce Reliance on Chinese APIs
The White House announced last week a suite of new initiatives aimed at bolstering domestic...
China’s CDE Launches Pilot Program for Electronic Drug Registration Filings
The National Medical Products Administration’s (NMPA) Center for Drug Evaluation (CDE) in China has issued...
China’s NHSA Releases 2024 National Reimbursement Drug List Adjustment Plan
The National Healthcare Security Administration (NHSA) has published the National Reimbursement Drug List (2024) adjustment...
CDE Seeks Public Input on Latest Batch of Generic Chemical Reference Preparations
The Center for Drug Evaluation (CDE), a key component of China’s National Medical Products Administration...
China’s NMPA Proposes Expedited Review for Clinically Urgent Overseas Drugs
The National Medical Products Administration (NMPA) has released a draft proposal titled “Announcement of the...
U.S. Lawmakers Question FDA on Discrepancies in Foreign Inspections of China and India
U.S. lawmakers have intensified their scrutiny of the FDA’s foreign inspection program, particularly for companies...